Healthy Living

New Research Could Change Cutaneous Lymphoma Treatment

New Research Could Change Cutaneous Lymphoma Treatment

New Research Could Change Cutaneous Lymphoma Treatment

Though new research, led by Dr. Pedro Quaglino from the University of Turin Medical School in Italy, is far from finished, the team has already discovered some interesting data trends.

Cutaneous lymphoma is a relatively rare disease, accounting for approximately 4 percent of non-Hodgkin lymphoma cases. Mycosis fungoides is the most common type, affecting about 1 in 100,000 people worldwide. Because of its rarity, doctors don’t know enough about this disease to best manage it. The disease usually strikes people during their mid-fifties and is very rare in children. However, it is possible for cutaneous lymphoma to affect a person at any age.